4Sc AG logo

VSC - 4Sc AG News Story

€1.38 -0.1  -3.5%

Last Trade - 12/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £62.1m
Enterprise Value £32.4m
Revenue £1.93m
Position in Universe 795th / 1053

BRIEF-4SC Announces Positive Domatinostat Pre-Clinical Data

Mon 12th October, 2020 6:35am
Oct 12 (Reuters) - 4SC AG  VSCk.DE :
    * ANNOUNCES AVAILABILITY OF A NEW PUBLICATION ON
DOMATINOSTAT
    * DATA SHOWS THAT DOMATINOSTAT NOT ONLY EXERTS DIRECT
ANTI-TUMORAL
EFFECTS, BUT ALSO RESTORES HLA CLASS I SURFACE EXPRESSION ON MCC
CELLS - AND AS A RESULT, RESTORES SURVIVING MCC CELLS'
SUSCEPTIBILITY TO RECOGNITION AND ELIMINATION BY CYTOTOXIC T
CELLS

Source text for Eikon:  ID:nPexZqFCwa 
Further company coverage:  VSCk.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.